uses JavaScript to provide the best possible experience for our content, but your browser has it disabled. Learn how to enable it here.


Posted February 16, 2012

Recall of Enhancement Supplement for Women -- Contains Drug

On Feb, 10, 2012, Regeneca, Inc. announced a voluntary nationwide recall of RegenArouse Natural Female Intimacy Enhancement. The product was distributed throughout the U.S. and Puerto Rico to Internet consumers. The product is distributed as a pink capsule sold individually in foil packets. Lot number 130100 is covered in this recall.

The company was informed that laboratory analysis conducted by FDA found that the product contains tadalafil. Tadalafil is an active ingredient of an FDA approved drug for erectile dysfunction (ED), making RegenArouse Natural Female Intimacy Enhancement an unapproved drug. The active drug ingredient is not listed on the product label. The undeclared ingredient may interact with nitrates found in some prescription drugs such as nitroglycerin and may lower blood pressure to dangerous levels. Consumers with diabetes, high blood pressure, high cholesterol, or heart disease often take nitrates. Additionally, the product may cause side effects, such as headaches and flushing.

Customers who have this product in their possession should stop using it immediately and contact their physician if they have experienced any problems that may be related to taking this product.

For additional information about the recall, use the link below. For information about natural approaches to sexual enhancement see's Product Review of Sexual Enhancers.